6533b86dfe1ef96bd12ca005
RESEARCH PRODUCT
Efficacy of a genetically engineered Candida albicans tet-NRG1 strain as an experimental live attenuated vaccine against hematogenously disseminated candidiasis.
Ashok K. ChaturvediAnna L. LazzellStephen P. SavilleCarlos MonteagudoJose L. Lopez-ribotsubject
Microbiology (medical)Neuregulin-1T-LymphocytesClinical BiochemistryImmunologyBiologyVaccines AttenuatedMicrobiologyMiceImmunityCandida albicansImmunology and AllergyAnimalsCandida albicansFungal vaccineVaccines SyntheticAttenuated vaccineStrain (biology)Candidiasisbiochemical phenomena metabolism and nutritionDisseminated Candidiasisbiology.organism_classificationVaccine ResearchVirologySurvival AnalysisVaccinationImmunizationFungal Vaccinesdescription
ABSTRACT We report on the efficacy of the genetically engineered Candida albicans tet-NRG1 strain as an experimental live, attenuated vaccine against disseminated candidiasis in both immunocompetent and immunodeficient mice mostly dependent on T-cell immunity. This experimental vaccination model may represent an important tool to unravel the mechanisms of protective immunity during candidiasis.
year | journal | country | edition | language |
---|---|---|---|---|
2009-01-16 | Clinical and vaccine immunology : CVI |